View larger version (11K):
[in a new window]
|
Typical industrial product-development pathway outlines steps necessary to initially identify a promising site of therapeutic action and potential therapy that affects that site and then validate that therapy for clinical use. In this diagram, targets are typically molecular steps or events in the physiology or pathophysiology that could be targeted with new therapies, such as a receptor or a signal transduction pathway. "Leads" are novel compounds or devices that might act on such targets.
|
